logo
Select company
Select metric
3.93Cash Ratio
VS
Market
91
Sector
83
Industry
74
History
78
$ 1.81Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information

Ticker

LCTX

Company Name

LINEAGE CELL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

LINEAGE CELL THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LCTX - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 42.27M3.93$ 10.76M
3/31/2025$ 47.89M3.66$ 13.09M
12/31/2024$ 45.79M3.28$ 13.98M
9/30/2024$ 27.75M2$ 13.86M
6/30/2024$ 29.62M1.94$ 15.28M
3/31/2024$ 43.58M2.58$ 16.89M
12/31/2023$ 35.44M1.97$ 17.96M
9/30/2023$ 31.47M1.98$ 15.88M
6/30/2023$ 33.89M2.11$ 16.05M
3/31/2023$ 15.45M0.9$ 17.23M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 4.2.
  • Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average Cash Ratio has been 3.31.
  • The median Cash Ratio for LINEAGE CELL THERAPEUTICS INC during this period was 2.7
  • LINEAGE CELL THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 9.16.
  • The lowest Cash Ratio recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe 0.6

LINEAGE CELL THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
TVRD : TVARDI THERAPEUTICS INC 1.93CRBU : CARIBOU BIOSCIENCES INC 0.87SRZN : SURROZEN INC 15.86PRTA : PROTHENA CORP PUBLIC LTD CO 5.48FATE : FATE THERAPEUTICS INC 1.8KRRO : KORRO BIO INC 1.96CAPR : CAPRICOR THERAPEUTICS INC 0.82TNXP : TONIX PHARMACEUTICALS HOLDING CORP 6.58OCGN : OCUGEN INC 1.52CRVO : CERVOMED INC 1.79

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for LINEAGE CELL THERAPEUTICS INC is calculated as follows: CashnEq [ $ 32.56M ] / LiabilitesC [ $ 7.75M ]
(=) Cash Ratio [ 4.2 ]

LCTX - Cash Ratio, Last 5 years

0.6

Minimum

Dec 31, 2022

9.16

Maximum

Jun 30, 2021

3.31

Average

2.7

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63